Item 5.07.Submission of Matters to a Vote of Security Holders.

On September 30, 2021, KalVista Pharmaceuticals, Inc. (the "Company") held its 2021 Annual Meeting of Stockholders ("Annual Meeting") and the following proposals were adopted:





   1. Election of three Class III directors, Albert Cha, Martin Edwards and Nancy
      Stuart (each to serve a three-year term, which will expire at the 2024
      Annual Meeting of Stockholders or until such time as their respective
      successors have been duly elected and qualified):






   Nominees      Shares For   Shares Against   Shares Abstaining   Broker Non-Votes
Albert Cha       16,672,347     5,474,494,            215              464,900
Martin Edwards   13,508,127     8,638,709             220              464,900
Nancy Stuart     21,393,389      753,360              307              464,900






   2. Ratification of the appointment of Deloitte & Touche LLP as the Company's
      independent registered public accounting firm for the fiscal year ending
      April 30, 2022:

Shares For Shares Against Shares Abstaining Broker Non-Votes 22,598,162 13,627

              167                 0




   3.  Approval, on a non-binding advisory basis, of the compensation paid by the
      Company to its named executive officers:




Shares For   Shares Against   Shares Abstaining   Broker Non-Votes
19,696,080     2,450,450             526              464,900

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses